MedMira Inc.
MedMira Inc. (MIR.V) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
mir.v · pe ratio · data through Jul 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for MedMira Inc. (MIR.V) measures how much investors pay for each dollar of the company's trailing earnings. MIR.V's current PE ratio of N/A is calculated by dividing its stock price of $0.06 by its TTM earnings per share of -$0.01.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-07-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
MedMira Inc.You MIR.V | $42M | N/A | — | -$0.01 |
 Arch Biopartners Inc. ARCH.V | $33M | N/A | — | -$0.02 |
 The Cannabist Company Holdings Inc. CBST.NE | $17M | N/A | — | -$0.23 |
 Covalon Technologies Ltd. COV.V | $60M | 27.97x | -34.2% | $0.08 |
 Defence Therapeutics Inc. DTC.CN | $29M | N/A | — | -$0.07 |
 1CM Inc. EPIC.CN | $19M | 57.07x | +34.2% | $0.00 |
 Gemina Laboratories Ltd. GLAB.CN | $5M | N/A | — | -$0.06 |
Industry Average 2 peers with valid PE | — | 42.52x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-07-31Latest FY2025 | — | $-0.01 | — | |
2024-07-31 FY2024 | — | $-0.00 | — | |
2023-07-31 FY2023 | — | $-0.00 | — | |
2022-07-31 FY2022 | — | $-0.00 | — | |
2021-07-31 FY2021 | — | $-0.00 | — | |
2020-07-31 FY2020 | — | $-0.00 | — | |
2019-07-31 FY2019 | — | $-0.00 | — | |
2018-07-31 FY2018 | — | $-0.00 | — | |
2017-07-31 FY2017 | — | $-0.00 | — | |
2016-07-31 FY2016 | — | $-0.01 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for MedMira Inc. (MIR.V) measures how much investors pay for each dollar of the company's trailing earnings. MIR.V's current PE ratio of N/A is calculated by dividing its stock price of $0.06 by its TTM earnings per share of -$0.01.
Frequently asked questions
MIR.V pe ratio · 6 questionsMIR.V's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.06 and TTM EPS of -$0.01. Data sourced from Financial Modeling Prep via MIR.V's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · MedMira Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09